Vigorous organ preserving therapy and multiorgan procurement: a way to increase organ availability.
Park
K M
KM
Department of Surgery, Asan Medical Center, College of Medicine, Ulsan University, Seoul, Korea.
Lee
S G
SG
Han
D J
DJ
Ha
H S
HS
Min
P C
PC
D000241:Adenosine; D000293:Adolescent; D000328:Adult; D000493:Allopurinol; D001926:Brain Death; D002102:Cadaver; D005947:Glucose; D005978:Glutathione; D006801:Humans; D006982:Hypertonic Solutions; D007328:Insulin; D007362:Intensive Care Units; D007723:Korea; D007902:Length of Stay; D008353:Mannitol; D008875:Middle Aged; D009926:Organ Preservation / Q000379:methods*; D019188:Organ Preservation Solutions; D011189:Potassium Chloride; D011343:Procaine; D011887:Raffinose; D012189:Retrospective Studies; D014019:Tissue Donors / Q000600:supply & distribution*; D009927:Tissue and Organ Procurement
C039984:Bretschneider cardioplegic solution; D006982:Hypertonic Solutions; D007328:Insulin; D019188:Organ Preservation Solutions; C055206:University of Wisconsin-lactobionate solution; D008353:Mannitol; D011343:Procaine; D000493:Allopurinol; D011189:Potassium Chloride; D005978:Glutathione; D005947:Glucose; D000241:Adenosine; D011887:Raffinose